ERBB2 and cancer: Like all cancers, it is considered a heterogeneous type, and the biological behavior, treatment response, and clinical outcomes are closely related to the molecular typing of breast cancer determined by the estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and KI-67.